Teva’s fresh troubles over drug safety, Bollygarchs drug ‘price-gouging’ in Britain, Sun Pharma downsizes U.S. operations
This week’s Phispers takes you through pharmaceutical news from across the globe – from
Does speedy action by European agencies suggest revival of API production in the West?
Recently announced regulatory
action against Indian and Chinese companies is creating a significant